Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

Conditions: Advanced Prostate Adenocarcinoma; Stage III Prostate Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8 Interventions: Drug: Abiraterone; Procedure: Biospecimen Collection; Drug: Darolutamide; Drug: Prednisone Sponsors: Mamta Parikh; National Cancer Institute (NCI) Recruiting

https://clinicaltrials.gov/study/NCT06173362

Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials